IPIX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 23:09):

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective...

Stats
今日成交量	58 000.00
平均成交量	504 008
市值	616 817
EPS	$0 ( 2024-04-12 )
下一个收益日期	( $0 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.120
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2022-12-30	Ehrlich Leo	Sell	11 307 527	Class B Common Stock
2021-10-10	Harness Jane A.	Buy	500 000	Stock Option
2020-09-11	Harness Jane A.	Buy	58 394	Class A Common Stock
2019-09-01	Harness Jane A.	Buy	58 394	Class A Common Stock
2020-09-11	Harness Jane A.	Sell	21 606	Class A Common Stock

INSIDER POWER
-100.00
Last 91 transactions
Buy: 118 435 245 \| Sell: 65 639 262

Innovation 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Innovation 财务报表

Annual	2023
营收:	$0
毛利润:	$-373 000 (0.00 %)
EPS:	$-0.00630

FY	2023
营收:	$0
毛利润:	$-373 000 (0.00 %)
EPS:	$-0.00630

FY	2022
营收:	$18 000.00
毛利润:	$-364 000 (-2 022.22 %)
EPS:	$-0.0142

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.0400

Financial Reports:

No articles found.

Innovation

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company is also developing Kevetrin, an anti-cancer compound for treating ovarian cancer. It has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.

实时更新： Innovation [IPIX]

Upcoming Earnings Alert